Russian government to subsidize labeling costs of pharma producers

The Russian government has announced that it will provide subsidies for domestic drugmakers and foreign companies operating in the local market for the partial cover their costs, associated with the forthcoming introduction of labeling procedure in the domestic pharmaceutical market, reports The Pharma Letter’s local correspondent.

It is planned that these subsidies will be distributed by the Industrial Development Fund, which is a public fund affiliated with the Russian government.

A spokesman of the Russian Ministry of Health said planned labeling of drugs in Russia pursues two major goals: fighting counterfeits in the market and establishing a control system for the movement of drugs from producer to patient.